By Ho Man Chan, Cheryl H Arrowsmith
Epigenetics is one of the fastest moving fields in drug discovery, with almost every large pharmaceutical company, and a substantial number of biotechnology companies, targeting epigenetic processes to treat diseases ranging from cancer to Huntington’s disease and from inflammation to sickle cell anaemia. This book aims to provide an overview of the key topics adopted in current epigenetic drug discovery programmes with a focus on major developments and new technologies. Importantly, the book incorporates case studies and outlines the key challenges and techniques employed to overcome them. The book is an ideal resource for researchers in both industry and academia with an interest in epigenetic and genetic factors involved in drug discovery, target ID and validation. The book is also an excellent introduction for postgraduates interested in the interface between epigenetics and pharmaceuticals.
Product Details
Publisher : Royal Society of Chemistry; 1st edition (September 30, 2024)
Language : English
Hardcover : 696 pages
ISBN-10 : 1837671109
ISBN-13 : 978-1837671106

The Johns Hopkins Internal Medicine Board Review: Certification and Recertification, 5th Edition (PDF)
Physical Medicine and Rehabilitation: An Update for Internists, An Issue of Medical Clinics of North America (Volume 104-2) (The Clinics: Internal Medicine, Volume 104-2)
Get Fit, Stay Fit, 7th Edition
Anatomy of Neuropsychiatry: The New Anatomy of the Basal Forebrain and Its Implications for Neuropsychiatric Illness 1st Edition
Clinical Research: From Proposal to Implementation 


Reviews
There are no reviews yet.